| Kratom legal status | Legal, unregulated |
| Kava legal status | Legal |
| CBD / hemp products | Legal (hemp-derived) |
| Psilocybin status | Prohibited |
As of October 2026, New Jersey has not enacted a kratom law: A4222 (the New Jersey Kratom Protection Act) and S2271 (a ban) remain in committee (New Jersey Legislature). Kratom (Mitragyna speciosa) remains legal for sale and possession in New Jersey with no statewide age, labeling, or purity standards beyond general consumer-protection law. The American Kratom Association maintains an authoritative tracker of KCPA adoption and amendments. Federally, kratom remains unscheduled by the DEA but has been the subject of FDA import alerts and warning letters citing safety concerns; the FDA does not approve kratom for any therapeutic use. As of October 2026, no federal action schedules the natural kratom leaf, but DEA published a temporary order placing three potent 7-OH-related compounds (mitragynine pseudoindoxyl, MGM-15 and MGM-16) in Schedule I on 26 August 2026, and on 14 October 2026 gave notice that it intends to temporarily schedule 7-hydroxymitragynine above a threshold recommended by HHS (Federal Register).
Kava (Piper methysticum) is legal for sale and consumption in New Jersey with no statewide scheduling or sales restrictions. Kava bars (commercial kava-serving establishments) operate in many US states. The FDA issued a 2002 consumer advisory about potential hepatotoxicity associated with kava use; subsequent research has generally found risk concentrated in poor-quality preparations, but the advisory remains in place and informs the regulatory posture. New Jersey may apply general dietary-supplement and food-safety rules to kava products.
Following the 2018 Farm Bill, hemp-derived CBD (cannabidiol from Cannabis sativa containing 0.3% delta-9 THC or less) is federally legal and may be sold in New Jersey subject to FDA dietary-supplement and food-additive rules and the state's industrial hemp program. Congress has since rewritten the federal definition of hemp (P.L. 119-37, enacted 12 November 2025): from 11 December 2026 a finished hemp product may hold no more than 0.4 mg total THC per container, and products with cannabinoids the plant cannot make lose hemp status on 12 November 2026 (Congressional Research Service). New Jersey may impose specific labeling, testing, or retail registration requirements on CBD products. Delta-8 THC, Delta-10 THC, and other "hemp-derived" cannabinoid isomers exist in a gray zone: federally permitted by some 2018 Farm Bill readings but increasingly restricted at state level. Verify the current New Jersey Department of Agriculture hemp program rules and any state-specific cannabinoid restrictions.
Psilocybin and psilocin remain DEA Schedule I controlled substances federally and are prohibited under New Jersey controlled-substance law. Sale, possession, and use carry criminal penalties under New Jersey statute. Some US municipalities have decriminalized possession through local-priority resolutions (Denver, Oakland, Santa Cruz, Seattle, Detroit, and others) but municipal decriminalization does not change state or federal scheduling. Verify any New Jersey city-level decriminalization status separately.
Federal law sets the nationwide minimum age for tobacco and nicotine products at 21 (Tobacco 21, 2019). Beyond tobacco/nicotine, US supplement age-restriction is patchwork: dietary supplements under DSHEA generally lack statutory minimum-purchase age at the federal level. New Jersey's Kratom Consumer Protection Act establishes a 21+ minimum purchase age for kratom products. Local municipalities may impose additional age restrictions on specific products (energy drinks, CBD, supplements with stimulant labels). Verify locally before retail operations.
Dietary supplements sold in New Jersey are subject to FDA labeling rules under the Dietary Supplement Health and Education Act (DSHEA, 1994), requiring Supplement Facts panel, ingredient list, "dietary supplement" identifier, manufacturer/packer/distributor name and address, and the FDA structure-function claim disclaimer where applicable. New Jersey may impose additional state-specific labeling, testing, or licensing requirements for high-risk categories (kratom, CBD, kava, sports supplements). Verify current rules with the New Jersey Department of Agriculture and Board of Pharmacy.
Once you understand New Jersey's legal framework for a supplement, the next question is the underlying evidence and risk profile. See our deep guides on supplement-cardiac safety, plus per-compound guides for ashwagandha, turmeric, and other commonly-asked supplements via our article index.
Yes. As of October 2026, New Jersey has not enacted a Kratom Consumer Protection Act or a kratom ban; A4222 and S2271 remain in committee. Kratom remains legal for sale and possession with no statewide age, labeling, or purity standards beyond general consumer-protection law. Federally, kratom remains unscheduled by DEA, but the FDA does not approve it for therapeutic use and has issued import alerts citing safety concerns. As of October 2026, no federal action schedules the natural kratom leaf, though DEA has temporarily placed three 7-OH-related compounds in Schedule I and has given notice that it intends to temporarily schedule 7-hydroxymitragynine.
Yes. Following the 2018 Farm Bill, hemp-derived CBD (with delta-9 THC ≤ 0.3%) is legal for sale in New Jersey subject to FDA dietary-supplement and food-additive rules. From 11 December 2026, the federal hemp definition (P.L. 119-37) also caps a finished hemp product at 0.4 mg total THC per container. Verify state-specific labeling, testing, and retail-registration requirements. Hemp-derived intoxicating cannabinoid isomers (Delta-8 THC, Delta-10 THC) sit in a gray zone, increasingly restricted at state level even where standard CBD is permitted.
Psilocybin remains DEA Schedule I federally. New Jersey prohibits sale, possession, and use of psilocybin under state controlled-substance law. Some US municipalities have decriminalized possession; verify local status separately.
Federal law sets a nationwide minimum age of 21 for tobacco and nicotine products. Beyond tobacco/nicotine, US dietary supplements under DSHEA generally lack statutory minimum-purchase age federally. New Jersey's Kratom Consumer Protection Act establishes a 21+ minimum purchase age for kratom products. Local municipalities may impose additional age restrictions on specific products (energy drinks, supplements with stimulant labels).
Claims about what a supplement or treatment does are only as good as the evidence behind them, and the sources below are the primary public ones. They are linked so a reader can check any statement here against the underlying research rather than taking this page's word for it.
This page summarises published evidence. It is not medical advice, and a reader's own clinician decides what applies to them.